Details der Publikation - Primary surgical treatment of nasal vestibule cancer

Primary surgical treatment of nasal vestibule cancer : therapeutic outcome and reconstructive strategies / K. Zaoui, P.K. Plinkert, P.A. Federspil

OBJECTIVE: The treatment strategy of squamous cell carcinoma of the nasal vestibule (SCCNV) is controversial. The objective of this study is to investigate the role of surgery, which is the preferred treatment option at our institution. - DESIGN: This was a monocentric prospective study of patients that were diagnosed with SCCNV between 2005 and 2013. - MATERIAL AND METHODS: Twenty-six patients were included. Tumors were staged using the UICC (7th edition) TNM classification of nasal cavity cancer and the classification proposed by Wang. The primary treatment was surgery in all patients. Survival data were statistically analyzed using the Kaplan-Meier method. The median follow-up time was 6 years. - RESULTS: Using the UICC classification, 9/26 tumors were staged as pT1 (35%), 7/26 as pT2 (27%), and 10/26 as pT4a (39%). Using the classification by Wang, 9/26 tumors were staged as pT1 (35%), 15/26 as pT2 (58%), and 2/26 as pT3 (8%). Reconstruction was performed using an implant-retained prosthesis in 50% of patients and by plastic surgery in the remaining 50%. Only 2/26 patients (8%) needed adjuvant radiation therapy. The five-year recurrence-free survival (RFS) was 86.7%, disease-specific survival was 96.2% and overall survival was 91.8% after five years. - CONCLUSION: Surgery in SCCNV gives an excellent prognosis and minimized the need for radiotherapy..

Medienart:	E-Artikel

Erscheinungsjahr:	2018
Erschienen:	2018

Enthalten in:	Zur Gesamtaufnahme - volume:56
Enthalten in:	Rhinology - 56(2018), 4, Seite 393-399

Sprache:	Englisch

Beteiligte Personen:	Zaoui, Karim, 1977- [VerfasserIn] Plinkert, Peter K. [VerfasserIn] Federspil, Philippe A., 1967- [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

Themen:	Adult Aged Aged, 80 and over Carcinoma, Squamous Cell Female Humans Male Middle Aged Nasal Cavity Neoplasm Staging Nose Neoplasms Prognosis Prospective Studies Prostheses and Implants Risk Factors Survival Rate Treatment Outcome

Anmerkungen:	Gesehen am 11.03.2020

Umfang:	7

doi:	10.4193/Rhin17.157

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	1692277170

Internformat


LEADER	01000caa a2200265 4500
001	1692277170
003	DE-627
005	20220818011938.0
007	cr uuu---uuuuu
008	200311s2018 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.4193/Rhin17.157 \|2 doi
035			\|a (DE-627)1692277170
035			\|a (DE-599)KXP1692277170
035			\|a (OCoLC)1341310142
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
100	1		\|a Zaoui, Karim \|d 1977- \|e verfasserin \|0 (DE-588)140238719 \|0 (DE-627)703610813 \|0 (DE-576)314596607 \|4 aut
245	1	0	\|a Primary surgical treatment of nasal vestibule cancer \|b therapeutic outcome and reconstructive strategies \|c K. Zaoui, P.K. Plinkert, P.A. Federspil
264		1	\|c 2018
300			\|a 7
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Gesehen am 11.03.2020
520			\|a OBJECTIVE: The treatment strategy of squamous cell carcinoma of the nasal vestibule (SCCNV) is controversial. The objective of this study is to investigate the role of surgery, which is the preferred treatment option at our institution. - DESIGN: This was a monocentric prospective study of patients that were diagnosed with SCCNV between 2005 and 2013. - MATERIAL AND METHODS: Twenty-six patients were included. Tumors were staged using the UICC (7th edition) TNM classification of nasal cavity cancer and the classification proposed by Wang. The primary treatment was surgery in all patients. Survival data were statistically analyzed using the Kaplan-Meier method. The median follow-up time was 6 years. - RESULTS: Using the UICC classification, 9/26 tumors were staged as pT1 (35%), 7/26 as pT2 (27%), and 10/26 as pT4a (39%). Using the classification by Wang, 9/26 tumors were staged as pT1 (35%), 15/26 as pT2 (58%), and 2/26 as pT3 (8%). Reconstruction was performed using an implant-retained prosthesis in 50% of patients and by plastic surgery in the remaining 50%. Only 2/26 patients (8%) needed adjuvant radiation therapy. The five-year recurrence-free survival (RFS) was 86.7%, disease-specific survival was 96.2% and overall survival was 91.8% after five years. - CONCLUSION: Surgery in SCCNV gives an excellent prognosis and minimized the need for radiotherapy.
650		4	\|a Adult
650		4	\|a Aged
650		4	\|a Aged, 80 and over
650		4	\|a Carcinoma, Squamous Cell
650		4	\|a Female
650		4	\|a Humans
650		4	\|a Male
650		4	\|a Middle Aged
650		4	\|a Nasal Cavity
650		4	\|a Neoplasm Staging
650		4	\|a Nose Neoplasms
650		4	\|a Prognosis
650		4	\|a Prospective Studies
650		4	\|a Prostheses and Implants
650		4	\|a Risk Factors
650		4	\|a Survival Rate
650		4	\|a Treatment Outcome
700	1		\|a Plinkert, Peter K. \|e verfasserin \|0 (DE-588)1032658509 \|0 (DE-627)739933043 \|0 (DE-576)169008908 \|4 aut
700	1		\|a Federspil, Philippe A. \|d 1967- \|e verfasserin \|0 (DE-588)1032667982 \|0 (DE-627)73862070X \|0 (DE-576)176922237 \|4 aut
773	0	8	\|i Enthalten in \|t Rhinology \|d Amsterdam : Journal Rhinology, c/o AMC, 1963 \|g 56(2018), 4, Seite 393-399 \|h Online-Ressource \|w (DE-627)37109626X \|w (DE-600)2120704-5 \|w (DE-576)113144008 \|x 1996-8604 \|7 nnns
773	1	8	\|g volume:56 \|g year:2018 \|g number:4 \|g pages:393-399 \|g extent:7
856	4	0	\|u https://doi.org/10.4193/Rhin17.157 \|x Verlag \|x Resolving-System \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ILN_2013
912			\|a ISIL_DE-16-250
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
936	u	w	\|d 56 \|j 2018 \|e 4 \|h 393-399 \|g 7
951			\|a AR
952			\|d 56 \|j 2018 \|e 4 \|h 393-399 \|g 7
980			\|2 2013 \|1 01 \|x DE-16-250 \|b 3606509715 \|c 00 \|f --%%-- \|d --%%-- \|e --%%-- \|j --%%-- \|y l01 \|z 11-03-20
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 00 \|s s \|a hd2018
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 01 \|s s \|0 (DE-627)1410508463 \|a wissenschaftlicher Artikel (Zeitschrift)
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 02 \|s s \|a per_3
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 03 \|s s \|a s_7
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 04 \|s p \|0 (DE-627)1513623230 \|a Zaoui, Karim
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 04 \|s k \|0 (DE-627)1416741259 \|a Universitäts-Hals-Nasen-Ohrenklinik
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 04 \|s s \|0 (DE-627)1410501914 \|a Verfasser
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 04 \|s s \|a pos_1
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 05 \|s p \|0 (DE-627)1450159583 \|a Plinkert, Peter K.
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 05 \|s k \|0 (DE-627)1416741259 \|a Universitäts-Hals-Nasen-Ohrenklinik
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 05 \|s s \|0 (DE-627)1410501914 \|a Verfasser
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 05 \|s s \|a pos_2
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 06 \|s p \|0 (DE-627)1450169023 \|a Federspil, Philippe A.
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 06 \|s k \|0 (DE-627)1416741259 \|a Universitäts-Hals-Nasen-Ohrenklinik
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 06 \|s k \|0 (DE-627)1416466967 \|a Medizinische Fakultät Heidelberg
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 06 \|s s \|0 (DE-627)1410501914 \|a Verfasser
982			\|2 2013 \|1 01 \|x DE-16-250 \|8 06 \|s s \|a pos_3

Primary surgical treatment of nasal vestibule cancer : therapeutic outcome and reconstructive strategies / K. Zaoui, P.K. Plinkert, P.A. Federspil

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände